Atlas Trials

Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma

Clinical trial NCT03801499 · WITHDRAWN

Trial details

NCT number
NCT03801499
Sponsor
Sun Yat-sen University
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Intrahepatic Cholangiocarcinoma
Start date
2018-09-01
Primary completion
2019-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.